A prospective survey on incidence, risk factors and therapy of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation.

Analysis of Survival Data

1984 • 6,206 citations

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators

1999 • 2,625 citations

Veno-occlusive Disease of the Liver and Multiorgan Failure after Bone Marrow Transplantation: A Cohort Study of 355 Patients

1993 • 1,173 citations

Regimen-related toxicity in patients undergoing bone marrow transplantation.

1988 • 876 citations

Venocclusive Disease of the Liver after Bone Marrow Transplantation: Diagnosis, Incidence, and Predisposing Factors

1984 • 845 citations

Toxic Injury to Hepatic Sinusoids: Sinusoidal Obstruction Syndrome (Veno-Occlusive Disease)

2002 • 661 citations

Analysing Survival Data From Clinical Trials and Observational Studies

1996 • 638 citations

The syndrome of hepatic veno-occlusive disease after marrow transplantation

1995 • 475 citations

Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the European Group for Blood and Marrow Transplantation. European Group for Blood and Marrow Transplantation Chronic Leukemia Working Party.

1998 • 344 citations

Association of busulfan area under the curve with veno-occlusive disease following BMT.

1996 • 318 citations

Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: response without significant toxicity in a high-risk population and factors predictive of outcome

2002 • 309 citations

Prior gemtuzumab ozogamicin exposure significantly increases the risk of veno-occlusive disease in patients who undergo myeloablative allogeneic stem cell transplantation

2003 • 304 citations

Venoocclusive disease of the liver after marrow transplantation: Histological correlates of clinical signs and symptoms

1994 • 291 citations

Once-daily intravenous busulfan given with fludarabine as conditioning for allogeneic stem cell transplantation: Study of pharmacokinetics and early clinical outcomes

2002 • 285 citations

Venoocclusive disease of the liver: development of a model for predicting fatal outcome after marrow transplantation.

1993 • 257 citations

Treatment of Severe Veno-Occlusive Disease With Defibrotide: Compassionate Use Results in Response Without Significant Toxicity in a High-Risk Population

1998 • 255 citations

Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation

2002 • 239 citations

Marrow transplantation for patients with thalassemia: results in class 3 patients

1996 • 219 citations

Defibrotide in the treatment of children with veno-occlusive disease (VOD): a retrospective multicentre study demonstrates therapeutic efficacy upon early intervention

2003 • 205 citations

Prevention of hepatic veno-occlusive disease after bone marrow transplantation by continuous infusion of low-dose heparin: a prospective, randomized trial [see comments]

1992 • 190 citations

Treatment of Hepatic Venocclusive Disease With Recombinant Human Tissue Plasminogen Activator and Heparin in 42 Marrow Transplant Patients

1997 • 189 citations

Second allogeneic marrow transplantation for patients with recurrent leukemia after initial transplant with total-body irradiation-containing regimens.

1993 • 186 citations

Ursodiol Prophylaxis against Hepatic Complications of Allogeneic Bone Marrow Transplantation

1998 • 184 citations

Defibrotide for the treatment of hepatic veno‐occlusive disease: results of the European compassionate‐use study

2000 • 184 citations

Hepatitis C virus infection and bone marrow transplantation: A cohort study with 10-year follow-up

1999 • 156 citations

Reduced intensity haemopoietic stem-cell transplantation for treatment of non-malignant diseases in children

2004 • 156 citations

The Japanese multicenter open randomized trial of ursodeoxycholic acid prophylaxis for hepatic veno-occlusive disease after stem cell transplantation

2000 • 146 citations

Treosulfan and fludarabine: a new toxicity-reduced conditioning regimen for allogeneic hematopoietic stem cell transplantation

2003 • 145 citations

Veno‐occlusive disease of the liver after hemopoietic cell transplantation

2000 • 140 citations

Risk factors for hepatic veno-occlusive disease after high-dose busulfan-containing regimens followed by autologous bone marrow transplantation: a study in 136 children.

1992 • 138 citations

Prevention of veno-occlusive disease with defibrotide after allogeneic stem cell transplantation

2004 • 127 citations

Hepatic Venoocclusive Disease in Blood and Bone Marrow Transplantation in Children and Young Adults: Incidence, Risk Factors, and Outcome in a Cohort of 241 Patients

2002 • 124 citations

Incidence, survival and risk factors for the development of veno-occlusive disease in pediatric hematopoietic stem cell transplant recipients

2003 • 123 citations

Use of prostaglandin E1 for prevention of liver veno‐occlusive disease in leukaemic patients treated by allogeneic bone marrow transplantation

1990 • 116 citations

A randomized controlled trial of pentoxifylline for the prevention of regimen-related toxicities in patients undergoing allogeneic marrow transplantation

1993 • 99 citations

LOW MOLECULAR WEIGHT HEPARIN FOR THE PREVENTION OF VENO-OCCLUSIVE DISEASE OF THE LIVER IN BONE MARROW TRANSPLANTATION PATIENTS1

1996 • 99 citations

Veno-occlusive disease: cytokines, genetics, and haemostasis

2003 • 98 citations

Dose-escalated treosulphan in combination with cyclophosphamide as a new preparative regimen for allogeneic haematopoietic stem cell transplantation in patients with an increased risk for regimen-related complications

2004 • 96 citations

Veno-occlusive disease of the liver after allogeneic bone marrow transplantation in children with hematologic malignancies: incidence, onset time and risk factors

1998 • 92 citations

A randomized trial of heparin plus ursodiol vs heparin alone to prevent hepatic veno-occlusive disease after hematopoietic stem cell transplantation

2002 • 91 citations

THE PATHOLOGY, DIAGNOSIS, AND TREATMENT OF HEPATIC VENO‐OCCLUSIVE DISEASE: CURRENT STATUS AND NOVEL APPROACHES

1999 • 90 citations

Doppler sonography: a noninvasive method for evaluation of hepatic venocclusive disease.

1990 • 90 citations

Decreased incidence of hepatic veno-occlusive disease and fewer hemostatic derangements associated with intravenous busulfan vs oral busulfan in adults conditioned with busulfan + cyclophosphamide for allogeneic bone marrow transplantation

2004 • 86 citations

Hepatic Veno-Occlusive Disease following Hematopoietic Stem Cell Transplantation

2001 • 73 citations

Prognostic value of doppler-ultrasonography in hepatic veno-occlusive disease

2002 • 69 citations

Hepatic veno-occlusive disease in children undergoing bone-marrow transplantation: usefulness of sonographic findings

2001 • 63 citations

The effect of metronidazole on busulfan pharmacokinetics in patients undergoing hematopoietic stem cell transplantation

2003 • 61 citations

Phase II trial of heparin prophylaxis for veno-occlusive disease of the liver in children undergoing bone marrow transplantation.

1996 • 61 citations

HLA-haploidentical blood progenitor cell transplantation in osteopetrosis

2002 • 60 citations

Pharmacokinetics and individualized dose adjustment of intravenous busulfan in children with advanced hematologic malignancies undergoing allogeneic stem cell transplantation

2004 • 57 citations

Chronic graft-versus-host disease: where do we go from here?

2004 • 47 citations

Veno-occlusive disease of the liver following high-dose chemotherapy and autologous bone marrow transplantation in children with solid tumors: incidence, clinical course and outcome.

1988 • 45 citations

Prevention and Treatment of Hepatic Venocclusive Disease after High-Dose Cytoreductive Therapy

1998 • 28 citations

The Relevance of Plasminogen Activator Inhibitor 1 (PAI-1) as a Marker for the Diagnosis of Hepatic Veno-Occlusive Disease in Patients after Bone Marrow Transplantation

1999 • 25 citations

Role of fibrinolytic and clotting parameters in the diagnosis of liver veno-occlusive disease after hematopoietic stem cell transplantation in a pediatric population

2005 • 21 citations

Color-flow imaging sonography of portal and hepatic vein flow to monitor fibrinolytic therapy with r-TPA for veno-occlusive disease following myeloablative treatment

1998 • 14 citations